Earnings Grew Faster Than the 6.2% CAGR Delivered to Impulse (Qingdao) Health TechLtd (SZSE:002899) Shareholders Over the Last Three Years
Earnings Grew Faster Than the 6.2% CAGR Delivered to Impulse (Qingdao) Health TechLtd (SZSE:002899) Shareholders Over the Last Three Years
It's been a soft week for Impulse (Qingdao) Health Tech Co.,Ltd. (SZSE:002899) shares, which are down 14%. But don't let that distract from the very nice return generated over three years. After all, the share price is up a market-beating 18% in that time.
对于青岛心浪健康科技有限公司(SZSE:002899)的股票来说,这是一个疲软的一周,下跌了14%。 但不要因此而忽视过去三年中创造的非常不错的回报。 毕竟,股价在这段时间内上涨了超过市场18%。
In light of the stock dropping 14% in the past week, we want to investigate the longer term story, and see if fundamentals have been the driver of the company's positive three-year return.
鉴于股票在过去一周下跌了14%,我们想调查长期图片,并查看基本面是否是公司三年回报的驱动力。
In his essay The Superinvestors of Graham-and-Doddsville Warren Buffett described how share prices do not always rationally reflect the value of a business. One way to examine how market sentiment has changed over time is to look at the interaction between a company's share price and its earnings per share (EPS).
在他的《格雷厄姆和道德斯维尔的超级投资者》一文中,沃伦·巴菲特描述了股价并不总是合理反映企业价值的方法。检验市场情绪如何随时间变化的一种方法是观察公司股价和每股收益(EPS)之间的互动关系。
During three years of share price growth, Impulse (Qingdao) Health TechLtd achieved compound earnings per share growth of 25% per year. The average annual share price increase of 6% is actually lower than the EPS growth. Therefore, it seems the market has moderated its expectations for growth, somewhat.
在三年的股价增长期间,青岛心浪健康科技有限公司实现了每年25%的复合每股收益增长。 平均每年6%的股价增长实际低于每股收益的增长。 因此,市场似乎已经适度降低了对增长的预期。
The company's earnings per share (over time) is depicted in the image below (click to see the exact numbers).
该公司的每股收益(随时间的推移)如下图所示(单击可查看确切数字)。
![big](https://usnewsfile.moomoo.com/public/MM-PersistNewsContentImage/7781/20241024/0-130849b23013763cafd227550ae8ef79-0-cbd3bf7cfc9288d13fc5fce819f8af69.png/big)
It might be well worthwhile taking a look at our free report on Impulse (Qingdao) Health TechLtd's earnings, revenue and cash flow.
值得一看的是我们对冲动(青岛)医疗科技有限公司的收益、营业收入和现金流的免费报告。
A Different Perspective
不同的观点
Impulse (Qingdao) Health TechLtd shareholders gained a total return of 5.8% during the year. Unfortunately this falls short of the market return. On the bright side, that's still a gain, and it's actually better than the average return of 3% over half a decade This could indicate that the company is winning over new investors, as it pursues its strategy. It's always interesting to track share price performance over the longer term. But to understand Impulse (Qingdao) Health TechLtd better, we need to consider many other factors. Case in point: We've spotted 1 warning sign for Impulse (Qingdao) Health TechLtd you should be aware of.
冲动(青岛)医疗科技有限公司的股东在一年内总回报为5.8%。不幸的是,这低于市场回报。然而,在光明的一面,这仍然是一笔收益,实际上比半个世纪以来的3%的平均回报更好。这可能表明公司正在赢得新投资者的青睐,因为它实施其策略。长期追踪股价表现总是很有趣。但要更好地了解冲动(青岛)医疗科技有限公司,我们需要考虑许多其他因素。例如:我们发现了1个冲动(青岛)医疗科技有限公司的警告标志,您应该注意。
Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of companies we expect will grow earnings.
当然,您可能在其他地方找到一家出色的企业进行投资。因此,请查看我们预计将实现盈利增长的公司的免费列表。
Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.
请注意,本文引用的市场回报反映了目前在中国交易所上市的股票的市场加权平均回报。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。